Ineffectiveness of myrrh-derivative Mirazid against schistosomiasis and fascioliasis in humans.

East Mediterr Health J

Department of Parsitology, Medical Research Institute, University of Alexandria, Alexandria, Egypt.

Published: September 2010

The present study assessed the schistosomicidal and fasciolicidal actions of the myrrh-derivative Mirazid in an area of low schistosomiasis transmission. A total of 27 patients infected with Schistosoma mansoni and 16 with Fasciola spp. received the maximum recommended dose of Mirazid. Pretreatment egg counts in 4 Kato-Katz slides were compared with similar counts in stool samples collected 1 and 2 months after treatment. Standard procedures and quality control measures were followed. The results revealed that Mirazid used as schistosomicidal or fasciolicidal agent in the maximum recommended dose has a low cure rate and produced a negligible reduction in egg counts. Prescribing such an ineffective drug in Egypt might endanger the achievements of the schistosomiasis control strategy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

myrrh-derivative mirazid
8
schistosomicidal fasciolicidal
8
maximum recommended
8
recommended dose
8
egg counts
8
ineffectiveness myrrh-derivative
4
mirazid
4
mirazid schistosomiasis
4
schistosomiasis fascioliasis
4
fascioliasis humans
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!